A triumph of teamwork and collaboration: MSSRF awards 3.2M to Canadian pediatric MS research group
Thinking back to my days in the lab, one thing that sticks out in my mind is the importance of teamwork. Collaborative research…
Adapting your sartorial choices: Dressing for MS
“Vain trifles as they seem, clothes have, they say, more important offices than to merely keep us warm. They change our view of…
MS Bike landscapes #1: Grand Bend vs. Wolfville
As Canadians, we know better than anyone how fleeting the joys of summer can be. We pack in as many weekend plans as…
Your simple guide to MS Bike fundraising
Six MS Bike tours have already taken place across Canada this year, and we’ve raised more than $2.6 million for Canadians living with…
One phone call – a life changed forever.
Listen to the clip above to hear Allie’s reaction to the news of her scholarship. I’m excited to announce that Allie Sherwin, whose…
Sometimes, it’s not MS: My journey with neuromyelitis optica
by Lelainia Lloyd, guest blogger You may have heard the acronym “NMO” floating around the MS community and wondered what it means. NMO…
We want to hear from you!
The Canadian Agency for Drugs and Technologies in Health (CADTH) is conducting a drug review for an MS treatment called peginterferon beta-1a. Marketed as Plegridy(TM) by Biogen, this drug…
What is MS?
Canada has one of the highest rates of multiple sclerosis (MS) in the world, with an estimated 77,000 Canadians living with the disease. While it is most often diagnosed in young adults aged 20 to 49, younger children and older adults are also diagnosed with the disease.